become a new research hot spot. It can enhance the immune function of the patient's body, exert an antitumor effect, and improve the tumor treatment effect (Reck, 2017; Wu, Kao, & Lai, 2018) . The cells that mediate the body's antitumor immunity are mainly T cells and macrophages.
Previous studies have indicated that macrophages have the effect of killing tumor cells (Bayik, Tross, & Klinman, 2018; Zheng et al., 2018) . Macrophages mainly differentiate into M1 and M2, and play different roles in tumor development (den Breems & Eftimie, 2016) .
M1 macrophages can secrete IL-12, NO, ROI and IL-1, IL-6, TNF-α, and other pro-inflammatory cytokines, which can induce Th1-type cell activation to a certain extent (Henao Agudelo et al., 2017; Rahat & Jivan, 2016; Zhang et al., 2016) . T cell-mediated cellular immunity is the main mechanism of the body's antitumor effect. T cells can be divided into two subgroups of CD4 + T cells and CD8 + T cells. Early studies have found that CD4 + T cells can be divided into two cell subpopulations, Th1 cells and Th2 cells, which play different roles in the development of tumors (Hirahara & Nakayama, 2016; Tsuda et al., 2017) . After activation, Th1 cells mainly secrete cytokines such as IFN-γ, IL-12, and TNF-α, which have significant anti-intracellular bacteria, viral infections, and antiviral effects (Hwang, Kim, Lee, & Lee, 2012; Soleimani, Jameie, Barati, Mehdizadeh, & Kerdari, 2014) .
The protein of silkworm pupae has been thought to be a new available source of high-quality protein that contains all the amino acids needed by the human body (Zhou & Han, 2006) . The silkworm peptide can be enzymatically hydrolyzed from silkworm protein. At present, the research on silkworm peptide mainly focuses on the physical properties and nutritional function analysis of silkworm peptide. There is little research on its immunity-related function (Nakahara, Kanamori, Kiuchi, & Kamimura, 2003; Wang, Wang, Liu, & Jin, 2017) . There is no relevant research on the mechanism of the medicinal value of silkworm peptide.
In this study, the immunity-related silkworm peptide was studied in depth. Lewis lung cancer xenograft model mice were established, and different doses of silkworm peptides were used for in vivo immune. The molecular mechanism of activation TH1 and polarization of M1 macrophages were studied for the first time, which laid the experimental foundation for its therapeutic use or adjuvant drug use.
| MATERIAL S AND ME THODS

| Preparation of silkworm peptide
Silkworm protein was enzymatically hydrolyzed with alkaline protease (China Pangbo Biological Co., Ltd.) at 55°C for 2.5 hr with solid-liquid ratio of 1:7 and enzyme concentration of 7%. In this study, Sephadex G-25 cation exchange chromatography column was used to separate and purify the silkworm peptide after debitterizing treatment. In this experiment, the molecular weight of the silkworm peptide after separation and purification was determined. Compared with the electrophoresis map of low molecular weight protein standards, the molecular weight of silkworm protein was greatly reduced after alkaline protease hydrolysis. The molecular weight of the active peptide after enzymatic hydrolysis was around 3 kDa.
| Establishment of Lewis lung cancer mouse model and in vivo immunization
Twenty BALB/C mice (18-20 g) were randomly selected, and 0.2 ml (2 × 10 6 cells) of LLC1 cells was injected into the right side of each mouse. Mice were immunized 3 days later. The specific method is as follows: 20 mice were classified into four groups (n = 5): PBS control group (400 μl PBS), low-dose group (10 μg silkworm peptide), medium-dose group (20 μg silkworm peptide), and high-dose group (50 μg silkworm peptide).
PBS and silkworm peptide were subcutaneously injected at the back of the neck and bilateral inguinal injection. The second immunization was performed in the same manner at 7 days after the first immunization. Mice were received immunization for twice.
| Mouse spleen lymphocyte proliferation detected by WST1 test
The Lewis lung cancer model mice were sacrificed by cervical dislocation. The spleen lymphocytes were isolated from the mouse lymphocyte separation solution, and 1 × 10 6 cells per well were cultured in 96-well plates for 48 hr. Each group had three duplicate wells. They were cultured in DMEM medium (containing 10% (v/v) fetal bovine serum, 100 U/ml penicillin, 100 μg/ml streptomycin); digested with trypsin, papain compound protease, and alkaline protease hydrolysate at a concentration of 20 μg/ml, respectively; and incubated for 48 hr at 37°C in a 5% CO 2 incubator. One hundred microliter of the cell culture supernatant was aspirated, 10 μl of WST1 reagent was added, and A450 was measured at 37°C for 1 hr in the dark. Cell proliferation ability was expressed as relative cell viability: relative cell viability = (A450 experimental group −A450 control group )/A450 control group .
| Levels of IFN-γ and IL-4 detected by ELISA
The spleen lymphocytes of the Lewis lung cancer model mice were isolated and cultured for 48 hr, and the cell culture supernatant was collected. The levels of IFN-γ and IL-4 in the cell culture supernatant were measured according to the ELISA kit instructions.
| Phagocytosis test of mouse peritoneal cavity macrophages
The mice were sacrificed by cervical dislocation. The 5 ml of PBS was injected into the abdominal cavity of the mouse using a syringe, and mice were gently massaged at the injection site for 2 min. The peritoneal fluid was aspirated using a pipette, centrifuged at 137 g for 5 min, and washed three times with 5 ml PBS at 137 g for 5 min. IMDM medium was added into 96-well plates at 4 × 10 5 cells per well. After incubated for 3 hr at 37°C in a 5%
CO 2 cell incubator, the unattached cells were removed with PBS.
The cells were again cultured in a CO 2 cell incubator for 48 hr. 
| Detection of TLR2 mRNA expression in mouse CD4 + T cells by qRT-PCR
The TLR2 mRNA primer sequence is as follows: Forward: 5′-GCTTCGTTGTTCCCTGTGTT-3′; Reverse: 5′-AGTGGTTGTCGCCTG CTT-3′. Activated CD4 + T cells were stimulated in vitro and cultured at 37°C for 2 hr. The 1.0 × 10 6 cells were collected from each group and placed in an EP tube. And 0.5 ml Trizol was added, mixed well, and placed at room temperature for 5 min; 100 μl of chloroform was added, mixed vigorously for 15 s, placed at room temperature for 3 min, and centrifuged at 13,685 g for 10 min at 4°C. The upper aqueous phase was added into a new EP tube, and an equal volume of isopropanol was added, placed at room temperature for 10 min, and centrifuged at 13,685 g for 10 min at 4°C. The supernatant was removed; 5 ml of 75% ethanol (DEPC water configuration) was added, mixed, and centrifuged at 7,698 g for 5 min at 4°C. It was dried for 5 min, and 15 μl of DEPC water was added to dissolve the RNA.
A total of 1 μg of RNA and 1 μl of Oligod (T) were added to DEPC water to make a total volume of 10.5 μl at 70°C water bath for 10 min and quickly placed on ice for 3 min. The 4 μl M-MLV buffer, 4 μl dNTP, 1 μl RTase M-mlv, and 0.5 μl RTase inhibitor were added, and the following reactions were carried out in a PCR instrument: 42°C, 1 hr; 70°C, 15 min. After the reaction, it was cooled on ice for 20 min.
The 1 μl of cDNA that was diluted 10 times, 0.6 μl of upstream and downstream primers, 10 μl of SyBR, and 7.8 μl of ddH 2 0 were added, and qRT-PCR product was performed in a qRT-PCR instrument.
| Western blot analysis of TLR2 signaling pathway-related protein expression
The 1.5 × 10 6 activated CD4 + T cells were collected from each group, and 150 μl of cell lysate was added, lysed on ice for 30 min, and centrifuged at 13,685 g at 4°C. The supernatant was collected for 15 min. Protein concentration was determined according to the BCA kit instructions. 20 μg of protein was added into 5× loading buffer, boiled at 100°C for 5 min, and separated by SDS-PAGE. The protein was transferred into the PVDF membrane for 2 hr and then placed in 5% skim milk powder (PBST dissolved) on a shaker at room temperature for 2 hr. After blocked by 5% skim milk powder, the corresponding primary antibodies were TLR2, TLR4, TLR9, MyD88, TRIF, TRAF3, TRAF6, IκB, p-IκB, and β-actin. β-actin was used as an internal reference. It was shaken for 2 hr at room temperature (or overnight at 4°C) and washed three times with PBST. The 1:10,000 diluted goat anti-mouse IgG-HRP or goat anti-rabbit IgG-HRP was added, shaken at room temperature for 2 hr, and washed three times with PBST. ECL reagent was used to develop color, and images were acquired according to the ECL detector operating instructions.
| Statistical analysis
Statistical analysis was performed on the relevant data using the SPSS 17.0 software processing system, and p < 0.05 was defined to be a significant difference. The t test was used for comparison between the different groups, and the data were expressed by x ± SD. All data in this study were average results from three repeated tests.
| RE SULTS
| Effect of silkworm peptide on the growth of Lewis lung cancer xenografts in mice
The volume of Lewis lung cancer xenografts in mice was compared (Figure 1 ). There was no significant change in tumor volume in the low-dose group compared with the control group. The growth rate of Lewis lung cancer xenografts in mice of the medium-dose group was significantly reduced, and the tumor volume was significantly smaller than that of the control group on the 14th day. The Lewis lung cancer xenografts in the high-dose group had the smallest volume. The above results suggested that the silkworm peptide could significantly inhibit the growth of Lewis lung cancer xenografts, and the effect was in a concentration-dependent manner.
| Effect of silkworm peptide on spleen lymphocyte proliferation in mice
The relative vitality of spleen lymphocytes in the low-dose immunized mice was 10.37%, and the difference was not statistically significant compared with the control group (p > 0.05). The relative vitality value of spleen lymphocytes in the medium-dose group was 23.61% and was significantly higher than the control group (p < 0.05). The relative cell viability of the high-dose group was the highest, which was 41.68%, suggesting that silkworm peptide could induce the proliferation of mouse spleen lymphocytes, and the effect was in a concentration-dependent manner (Figure 2a ).
| The levels of IFN-γ and IL-4 in spleen lymphocytes of Lewis lung cancer model mice
The IFN-γ level in the spleen lymphocyte supernatant of the Lewis lung cancer model mice immunized in the control group (784.54 pg/ ml) was lower than the low-dose group (832.67 pg/ml) (p > 0.05).
The IFN-γ levels in the medium-dose group (1,363.26 pg/ml) and high-dose group (1,895.42 pg/ml) were significantly higher than the control group (p < 0.05) (Figure 2b ). The levels of IL-4 were no significant change among different groups (Figure 2c ). These results suggested that silkworm peptide could induce IFN-γ secretion from lymphocytes of Lewis lung cancer model mice, and have no effect on the IL-4 secretion.
| Effect of silkworm peptide on the activity of peritoneal macrophages in Lewis lung cancer model mice
The experimental results were shown in Figure 2d . Compared with the control group, the A540 nm of the other three groups was increased to different extents, suggesting that silkworm peptide could increase the phagocytic activity of peritoneal macrophages in Lewis lung cancer model mice. However, there was no statistically significant difference in the phagocytic activity between the lowdose group and the control group (p > 0.05). Compared with the control group, the A540 nm in the medium-dose group was significantly increased, suggesting that the phagocytic activity of the peritoneal macrophages in the medium-dose group was significantly increased.
The A540 nm in the high-dose group was 0.38. The above experimental results suggested that silkworm peptide could significantly increase the phagocytic activity of peritoneal macrophages in Lewis lung cancer model mice, and the effect was in a concentration-dependent manner. 
| Effect of silkworm peptide on the proliferation of mouse spleen lymphocytes in vitro
The relative viability of the cells in 5 μg/ml silkworm protein group was 9.87% and was not significantly different from that of the control group. Compared with the control group, 10 and 20 μg/ml of silkworm peptides could significantly increase the relative viability (25.13% and 44.59%) of lymphocytes, and the relative viability value was gradually increased with the increase in active peptide concentration. The above results suggested that the silkworm peptide could induce the proliferation of mouse spleen lymphocytes, and the effect was in a concentration-dependent manner.
| Effect of silkworm peptide on CD4 + T-cell subsets in mouse lymphocytes
To further detect the cell subsets induced by silkworm peptides, mouse spleen lymphocytes were stimulated for 48 hr after different concentrations of silkworm peptide (5, 10, 20 μg/ml). Cells were stained with anti-CD3-PE, anti-CD4-PE-cy7, and anti-CD8-APC an-
tibodies. The percentage of CD4 + T cells and CD8 + T cells in this
range were detected by flow cytometry with CD3 + T cells (Figure 4 ).
In the control group, the proportion of CD3+ T cells in the CD8+
T cells was 8.5%. After stimulation with the silkworm peptide, the proportion of CD8 + T cells (5 μg/ml group, 9.2%; 10 μg/ml group, 11.1%; 20 μg/ml group, 11.3%) were not significantly different compared with the control group. The proportion of CD4 + T cells in the control group was 45.3%. After stimulation with 5 μg/ml silkworm peptide, the proportion of CD4 + T cells was increased to 50.1%, which was not statistically significant (p > 0.05). After stimulation with 10 μg/ml silkworm peptide, the proportion of CD4 + T cells was increased to 62.3%, which was significantly different from the control group (p < 0.05). The proportion of CD4 + T cells in the 20 μg/ml group was the highest (78.9%), which was significantly higher than the control group and the other two experimental groups. These 
| Proliferation of mouse CD4 + T cells
The immunomagnetic beads were used to sort the mouse spleen CD4 + T cells, the cells were labeled with CD4-PE-cy7 antibody, and the purity of CD4 + T cells was tested by flow cytometry. The percentage of CD4 + T cells was 97.1%, which met the experimental requirements. After stimulation with 5 μg/ml silkworm peptide, the relative viability was 11.45%. Compared with the control group, the difference was not statistically significant (p > 0.05). Compared with the control group, the relative viability values in 10 μg/ml (21.53%)
The flow cytometry of CD4 + T cell and CD8 + T cell stimulated with silkworm peptide
, and IL-10 (e) levels of Lewis lung carcinoma-bearing mice macrophage after immunized with silkworm peptides. * Indicated p < 0.05 compared with control group and 20 μg/ml groups (47.63%) were statistically significant (p < 0.05) (Figure 6a) . The above experimental results suggested that the silkworm peptide could directly induce the proliferation of activated mouse CD4 + T cells, and the effect was in a concentration-dependent manner.
| Effect of silkworm peptide on Th1 activation in mouse CD4 + T cells
The concentration of IFN-γ in 5 μg/ml group (886.31 pg/ml)
was not statistically significant difference from the control group (p > 0.05). The concentrations of IFN-γ in 10 and 20 μg/ ml groups were increased significantly and were statistically significant from control group (p < 0.05) (Figure 6b ). In addition, IL-4 concentrations were no significant differences among all groups (Figure 6c ), indicating that the silkworm peptide had no effect on the secretion of IL-4 by CD4 + T cells. These results suggested that the silkworm peptide could directly induce Th1 activation in mouse CD4 + T cells, and the effect was in a concentration-dependent manner.
| Activation of TLR2-mediated MyD88-dependent pathway
Compared with the control group, the expression level of TLR2 mRNA was increased in different degrees after activation of CD4 + T cells stimulated with silkworm peptide. Compared with the control group, the increase of TLR2 mRNA in the 5 μg/ml group was not significant (p > 0.05); the TLR2 mRNA in the 10 μg/ml group and 20 μg/ml groups were statistically significantly higher than the control group (p < 0.05) (Figure 6d ). (Fernandez et al., 2007) . In this study, silkworm peptide could induce Th1 activation and M1 type, which was dose-dependent. The silkworm peptide could play role in inhibiting tumor growth, and it may be related to TLR2-induced MyD88-dependent pathway in vitro.
Macrophages are important constituent cells of innate immunity
and play a wide-ranging role in the body's fight against foreign antigens (Bryan et al., 2018; Curtale, 2018) . In recent years, studies have found that macrophages play an important role in the development and progression of malignant tumors in addition to the traditional immunomodulatory effects Nie et al., 2017; Tanita et al., 2017) (Chi, Jiang, Lei, Shen, & Yang, 2016; Oishi et al., 2016) . M1 macrophages mainly secrete NO, IL-6, IL-12 and TNF-α, and other inflammatory factors . (Weiss, Raupach, Takeda, Akira, & Zychlinsky, 2004) . Through the in vivo experiments in this study,
we were unable to determine whether the silkworm peptide induced Th1 activation through direct or indirect effects. The previous study
found that E. coli maltose-binding protein can induce Th1 activation by activated CD4 + T cells through direct pathway (Fang et al., 2015) . It has been reported that in addition to high expression on antigen-presenting cells (APC), TLR2 is functionally expressed on CD4 + T cells and directly regulates the immune function of CD4 + T cells (Martino, Casetti, & Poccia, 2007) . Current studies have shown that activation of the TLR2 signaling pathway directly induces Th1 activation in CD4 + T cells (Liu, Zhai, et al., 2017; .
The study found that in vitro stimulation of mouse spleen CD4 + T cells after activation with CD3 antibody using TLR2 agonist-Pam3CKS for F I G U R E 7 Effect of silkworm peptides on TLR2, MyD88, and IκB expressions of activated CD4 + T cells detected by
Western blot
48 hr, the concentration of IFN-γ in cell culture supernatants could be significantly increased (Zhang, Sun, Wei, & Tian, 2005) . Another study indicated that Pam3CKS stimulated mouse CD4 + T cells after CD3
and CD28 antibody co-activation in vitro, and it could significantly increase IFN-γ secretion and reduce IL-4 secretion (Orr et al., 2013) .
It was speculated that the silkworm peptide may also induce Th1 activation through the TLR2 signaling pathway. Therefore, Western blot and qRT-PCR experimental techniques were used to detect changes in TLR2 mRNA and protein expression levels after silkworm peptide stimulation of CD4 + T cells. The results showed that different concentrations of silkworm peptide could significantly increase TLR2 mRNA and protein expression levels in vitro, and the effect was in a concentration-dependent manner. It was suggested that silkworm peptide could induce Th1 activation through TLR2 signaling pathway.
TLR2 is expressed on the cell surface and must bind to TLR1 or TLR6 to form a dimer, and binds to the corresponding ligand to induce activation of the signaling pathway (Choteau et al., 2017) .
The downstream signal molecule of TLR2 is MyD88. After binding to the corresponding ligand, TLR2 first activates MyD88 molecule, which in turn induces the activation of downstream signaling molecules and exerts corresponding biological functions, and this activation pathway becomes MyD88-dependent pathway (Liu, Zhai, et al., 2017; . The study has shown that if the TLR2 gene or MyD88 gene was knocked out, the mice were stimulated with the TLR2 agonist, and they were unable to induce DC cell maturation or induce B-cell activation (Fukata et al., 2008) . Western blot results showed that the expression level of MyD88 protein in TLR2 agonist-stimulated group was significantly increased in this experiment, suggesting that TLR2 could directly induce Th1 activation in CD4 + T cells by activating MyD88-dependent pathway in vitro.
This was highly consistent with the experimental results obtained in this study. In this study, results showed that stimulation of activated CD4 + T cells with different concentrations of silkworm peptide not only significantly up-regulated the expression of TLR2 protein, but also up-regulated the activation of MyD88 and I-kB. It was suggested that the TLR2-mediated MyD88-dependent pathway played an important role in the Th1 activation induced by the silkworm peptide.
However, the specific reasons for the induction of Th1 activation by MyD88-dependent pathway are still unclear. Some scholars believe that this effect of MyD88 molecule may be related to its ability to induce the activation of IL-1β and IL-18 receptor signaling pathway.
In conclusion, silkworm peptide could induce Th1 activation and M1 type polarization, which was dose-dependent and was relative to the effect of silkworm peptide on inhibiting tumor growth.
Silkworm peptide could directly induce M1 type polarization and Th1 activation via TLR2-induced MyD88-dependent pathway in vitro. However, this study was only performed in animal level, in order to verify the immune activity and molecular mechanism of silkworm peptide, and the further study is still needed.
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